Search research articles
Contact Us
Filters
Showing results (31-40 of 75) with videos related to
Page
of 8
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 1, 1985
Phase II study of a combination of mitomycin, doxorubicin and cisplatin in advanced sarcomas
J H Edmonson, H J Long, R L Richardson, et al.
Gynecologic Oncology
|
October 1, 1989
Endometrial stromal sarcoma: review of Mayo Clinic experience, 1945-1980
P A De Fusco, T A Gaffey, G D Malkasian, et al.
Cancer Treatment Reports
|
May 1, 1986
Phase II trials of recombinant leukocyte A interferon in disseminated malignant melanoma: results in 96 patients
E T Creagan, D L Ahmann, S Frytak, et al.
Cancer Treatment Reports
|
February 1, 1987
Phase II study of recombinant gamma-interferon in patients with advanced nonosseous sarcomas
J H Edmonson, H J Long, E T Creagan, et al.
Investigational New Drugs
|
August 1, 1991
Phase II evaluation of menogaril in patients with advanced hypernephroma
H J Long, M D Hauge, T M Therneau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1985
Phase II study of recombinant leukocyte A interferon (IFN-rA) plus cimetidine in disseminated malignant melanoma
E T Creagan, D L Ahmann, S J Green, et al.
Cancer Treatment Reports
|
September 1, 1987
Phase II study of recombinant interferon-gamma in patients with disseminated malignant melanoma
E T Creagan, D L Ahmann, H J Long, et al.
Investigational New Drugs
|
November 1, 1992
Phase II trial of intravenous hexamethylmelamine in patients with advanced ovarian cancer
M D Hauge, H J Long, L C Hartmann, et al.
Cancer
|
February 1, 1987
Three consecutive phase II studies of recombinant interferon alfa-2a in advanced malignant melanoma. Updated analyses
E T Creagan, D L Ahmann, S Frytak, et al.
American Journal of Clinical Oncology
|
October 1, 1988
Phase II evaluation of menogaril in women with metastatic breast cancer after failure of first-line chemotherapy
H J Long, D J Schaid, A J Schutt, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 75) with videos related to
Sort By:
Page
of 8
Cancer Chemotherapy and Pharmacology
|
January 1, 1985
Phase II study of a combination of mitomycin, doxorubicin and cisplatin in advanced sarcomas
J H Edmonson, H J Long, R L Richardson, et al.
Gynecologic Oncology
|
October 1, 1989
Endometrial stromal sarcoma: review of Mayo Clinic experience, 1945-1980
P A De Fusco, T A Gaffey, G D Malkasian, et al.
Cancer Treatment Reports
|
May 1, 1986
Phase II trials of recombinant leukocyte A interferon in disseminated malignant melanoma: results in 96 patients
E T Creagan, D L Ahmann, S Frytak, et al.
Cancer Treatment Reports
|
February 1, 1987
Phase II study of recombinant gamma-interferon in patients with advanced nonosseous sarcomas
J H Edmonson, H J Long, E T Creagan, et al.
Investigational New Drugs
|
August 1, 1991
Phase II evaluation of menogaril in patients with advanced hypernephroma
H J Long, M D Hauge, T M Therneau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1985
Phase II study of recombinant leukocyte A interferon (IFN-rA) plus cimetidine in disseminated malignant melanoma
E T Creagan, D L Ahmann, S J Green, et al.
Cancer Treatment Reports
|
September 1, 1987
Phase II study of recombinant interferon-gamma in patients with disseminated malignant melanoma
E T Creagan, D L Ahmann, H J Long, et al.
Investigational New Drugs
|
November 1, 1992
Phase II trial of intravenous hexamethylmelamine in patients with advanced ovarian cancer
M D Hauge, H J Long, L C Hartmann, et al.
Cancer
|
February 1, 1987
Three consecutive phase II studies of recombinant interferon alfa-2a in advanced malignant melanoma. Updated analyses
E T Creagan, D L Ahmann, S Frytak, et al.
American Journal of Clinical Oncology
|
October 1, 1988
Phase II evaluation of menogaril in women with metastatic breast cancer after failure of first-line chemotherapy
H J Long, D J Schaid, A J Schutt, et al.
Page
of 8